Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
Lung Cancer: Targets and Therapy · 2017
DOI: 10.2147/lctt.s105678 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lung Cancer: Targets and Therapy, 2017. Verfasst von Ashwin Somasundaram und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Zitieren
APA
Somasundaram, A., & Burns, T. F. (2017). Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives. Lung Cancer: Targets and Therapy. https://doi.org/10.2147/lctt.s105678
Vancouver
Somasundaram A, Burns TF. Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives. Lung Cancer: Targets and Therapy. 2017. doi:10.2147/lctt.s105678
BibTeX
@article{Somasundaram2017,
author = {Somasundaram, Ashwin and Burns, Timothy F},
title = {Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives},
journal = {Lung Cancer: Targets and Therapy},
year = {2017},
doi = {10.2147/lctt.s105678}
}
EUVIMED